Sign up for the QMED & MD+DI Daily newsletter.
Agreement signed for development of drug-coated stent.
Agreement signed for development of drug-coated stent. STS Biopolymers (Henrietta, NY; 716/321-1130) has agreed to develop a Medi-Coat drug-delivery coating for stents manufactured by B. Braun Medical (Bethlehem, PA; 800/359-2439). The coated stents will be designed to inhibit restenosis in patients. Medi-Coat drug-delivery technology makes possible the release of single drugs or multiple-drug combinations over times ranging from days to weeks. The drugs are delivered from the polymer matrix directly to the vessel wall. When used in combination
November 1, 2001
1 Min Read
.svg?width=850&auto=webp&quality=95&format=jpg&disable=upscale "Agreement signed for development of drug-coated stent.")
STS Biopolymers (Henrietta, NY; 716/321-1130) has agreed to develop a Medi-Coat drug-delivery coating for stents manufactured by B. Braun Medical (Bethlehem, PA; 800/359-2439). The coated stents will be designed to inhibit restenosis in patients. Medi-Coat drug-delivery technology makes possible the release of single drugs or multiple-drug combinations over times ranging from days to weeks. The drugs are delivered from the polymer matrix directly to the vessel wall. When used in combination with primer, the Medi-Coat drug-delivery coating will adhere permanently to the stents while providing the necessary flexibility, without cracking or flaking.
You May Also Like
.png?width=300&auto=webp&quality=80&disable=upscale)
